nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—ABCB1—Topotecan—cervical cancer	0.264	0.625	CbGbCtD
Loperamide—CYP3A4—Topotecan—cervical cancer	0.158	0.375	CbGbCtD
Loperamide—CALM2—semen—cervical cancer	0.0259	0.0823	CbGeAlD
Loperamide—CALM1—semen—cervical cancer	0.0258	0.0819	CbGeAlD
Loperamide—POMC—renal system—cervical cancer	0.0162	0.0515	CbGeAlD
Loperamide—POMC—female reproductive system—cervical cancer	0.013	0.0412	CbGeAlD
Loperamide—POMC—female gonad—cervical cancer	0.0118	0.0375	CbGeAlD
Loperamide—POMC—vagina—cervical cancer	0.0118	0.0373	CbGeAlD
Loperamide—CALM2—exocrine gland—cervical cancer	0.011	0.0348	CbGeAlD
Loperamide—CALM1—exocrine gland—cervical cancer	0.0109	0.0347	CbGeAlD
Loperamide—OPRD1—renal system—cervical cancer	0.00895	0.0284	CbGeAlD
Loperamide—Bullous eruption—Topotecan—cervical cancer	0.00779	0.227	CcSEcCtD
Loperamide—OPRK1—female reproductive system—cervical cancer	0.00688	0.0218	CbGeAlD
Loperamide—CALM3—uterine cervix—cervical cancer	0.00603	0.0191	CbGeAlD
Loperamide—CALM3—decidua—cervical cancer	0.00575	0.0182	CbGeAlD
Loperamide—CALM3—endometrium—cervical cancer	0.00546	0.0173	CbGeAlD
Loperamide—CALM3—mammalian vulva—cervical cancer	0.00528	0.0167	CbGeAlD
Loperamide—CALM3—uterus—cervical cancer	0.00503	0.016	CbGeAlD
Loperamide—CALM2—epithelium—cervical cancer	0.00478	0.0152	CbGeAlD
Loperamide—CALM1—epithelium—cervical cancer	0.00476	0.0151	CbGeAlD
Loperamide—CALM2—uterine cervix—cervical cancer	0.00474	0.015	CbGeAlD
Loperamide—CALM1—uterine cervix—cervical cancer	0.00472	0.015	CbGeAlD
Loperamide—CALM2—decidua—cervical cancer	0.00451	0.0143	CbGeAlD
Loperamide—CALM1—decidua—cervical cancer	0.00449	0.0143	CbGeAlD
Loperamide—CALM2—renal system—cervical cancer	0.00443	0.0141	CbGeAlD
Loperamide—CALM1—renal system—cervical cancer	0.00441	0.014	CbGeAlD
Loperamide—CALM2—endometrium—cervical cancer	0.00429	0.0136	CbGeAlD
Loperamide—CALM1—endometrium—cervical cancer	0.00427	0.0135	CbGeAlD
Loperamide—CALM2—mammalian vulva—cervical cancer	0.00415	0.0132	CbGeAlD
Loperamide—CALM1—mammalian vulva—cervical cancer	0.00413	0.0131	CbGeAlD
Loperamide—CALM3—female gonad—cervical cancer	0.00411	0.013	CbGeAlD
Loperamide—CALM3—vagina—cervical cancer	0.00409	0.013	CbGeAlD
Loperamide—CALM2—uterus—cervical cancer	0.00395	0.0125	CbGeAlD
Loperamide—CALM1—uterus—cervical cancer	0.00393	0.0125	CbGeAlD
Loperamide—CYP2C8—renal system—cervical cancer	0.00367	0.0117	CbGeAlD
Loperamide—CYP2C8—endometrium—cervical cancer	0.00355	0.0113	CbGeAlD
Loperamide—CALM2—female reproductive system—cervical cancer	0.00355	0.0113	CbGeAlD
Loperamide—CALM1—female reproductive system—cervical cancer	0.00353	0.0112	CbGeAlD
Loperamide—CYP2B6—renal system—cervical cancer	0.0033	0.0105	CbGeAlD
Loperamide—CALM2—female gonad—cervical cancer	0.00323	0.0102	CbGeAlD
Loperamide—CALM1—female gonad—cervical cancer	0.00322	0.0102	CbGeAlD
Loperamide—CALM2—vagina—cervical cancer	0.00321	0.0102	CbGeAlD
Loperamide—CALM1—vagina—cervical cancer	0.0032	0.0101	CbGeAlD
Loperamide—CYP2C8—female reproductive system—cervical cancer	0.00294	0.00933	CbGeAlD
Loperamide—CYP2C8—vagina—cervical cancer	0.00266	0.00844	CbGeAlD
Loperamide—CALM3—lymph node—cervical cancer	0.00264	0.00839	CbGeAlD
Loperamide—CYP2B6—female reproductive system—cervical cancer	0.00264	0.00837	CbGeAlD
Loperamide—CYP3A4—renal system—cervical cancer	0.00249	0.00789	CbGeAlD
Loperamide—CYP2D6—renal system—cervical cancer	0.00245	0.00777	CbGeAlD
Loperamide—CYP2B6—vagina—cervical cancer	0.00239	0.00757	CbGeAlD
Loperamide—Dermatitis bullous—Topotecan—cervical cancer	0.00234	0.0682	CcSEcCtD
Loperamide—Anaphylactoid reaction—Topotecan—cervical cancer	0.00231	0.0673	CcSEcCtD
Loperamide—CALM2—lymph node—cervical cancer	0.00208	0.00659	CbGeAlD
Loperamide—CALM1—lymph node—cervical cancer	0.00207	0.00656	CbGeAlD
Loperamide—CYP3A4—female reproductive system—cervical cancer	0.00199	0.00632	CbGeAlD
Loperamide—CYP2D6—female reproductive system—cervical cancer	0.00196	0.00622	CbGeAlD
Loperamide—ABCB1—epithelium—cervical cancer	0.0019	0.00602	CbGeAlD
Loperamide—ABCB1—uterine cervix—cervical cancer	0.00188	0.00597	CbGeAlD
Loperamide—ABCB1—decidua—cervical cancer	0.00179	0.00569	CbGeAlD
Loperamide—CYP2D6—female gonad—cervical cancer	0.00178	0.00566	CbGeAlD
Loperamide—ABCB1—renal system—cervical cancer	0.00176	0.00559	CbGeAlD
Loperamide—ABCB1—endometrium—cervical cancer	0.0017	0.0054	CbGeAlD
Loperamide—ABCB1—mammalian vulva—cervical cancer	0.00165	0.00523	CbGeAlD
Loperamide—ABCB1—uterus—cervical cancer	0.00157	0.00498	CbGeAlD
Loperamide—ABCB1—female reproductive system—cervical cancer	0.00141	0.00448	CbGeAlD
Loperamide—Immune system disorder—Topotecan—cervical cancer	0.0014	0.0407	CcSEcCtD
Loperamide—ABCB1—female gonad—cervical cancer	0.00128	0.00407	CbGeAlD
Loperamide—ABCB1—vagina—cervical cancer	0.00128	0.00405	CbGeAlD
Loperamide—Angioedema—Topotecan—cervical cancer	0.00123	0.0359	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00114	0.0332	CcSEcCtD
Loperamide—Discomfort—Topotecan—cervical cancer	0.00113	0.033	CcSEcCtD
Loperamide—Anaphylactic shock—Topotecan—cervical cancer	0.0011	0.032	CcSEcCtD
Loperamide—Nervous system disorder—Topotecan—cervical cancer	0.00108	0.0314	CcSEcCtD
Loperamide—Skin disorder—Topotecan—cervical cancer	0.00107	0.0311	CcSEcCtD
Loperamide—Dyspepsia—Topotecan—cervical cancer	0.000967	0.0282	CcSEcCtD
Loperamide—Gastrointestinal disorder—Topotecan—cervical cancer	0.000949	0.0277	CcSEcCtD
Loperamide—Fatigue—Topotecan—cervical cancer	0.000947	0.0276	CcSEcCtD
Loperamide—Constipation—Topotecan—cervical cancer	0.00094	0.0274	CcSEcCtD
Loperamide—Gastrointestinal pain—Topotecan—cervical cancer	0.000898	0.0262	CcSEcCtD
Loperamide—Urticaria—Topotecan—cervical cancer	0.000873	0.0254	CcSEcCtD
Loperamide—Abdominal pain—Topotecan—cervical cancer	0.000869	0.0253	CcSEcCtD
Loperamide—ABCB1—lymph node—cervical cancer	0.000825	0.00262	CbGeAlD
Loperamide—Hypersensitivity—Topotecan—cervical cancer	0.000809	0.0236	CcSEcCtD
Loperamide—Asthenia—Topotecan—cervical cancer	0.000788	0.023	CcSEcCtD
Loperamide—Pruritus—Topotecan—cervical cancer	0.000777	0.0227	CcSEcCtD
Loperamide—Diarrhoea—Topotecan—cervical cancer	0.000752	0.0219	CcSEcCtD
Loperamide—Dizziness—Topotecan—cervical cancer	0.000727	0.0212	CcSEcCtD
Loperamide—Vomiting—Topotecan—cervical cancer	0.000699	0.0204	CcSEcCtD
Loperamide—Rash—Topotecan—cervical cancer	0.000693	0.0202	CcSEcCtD
Loperamide—Dermatitis—Topotecan—cervical cancer	0.000692	0.0202	CcSEcCtD
Loperamide—Headache—Topotecan—cervical cancer	0.000688	0.0201	CcSEcCtD
Loperamide—Nausea—Topotecan—cervical cancer	0.000653	0.019	CcSEcCtD
Loperamide—CALM3—Signaling by FGFR in disease—EGFR—cervical cancer	0.000143	0.00063	CbGpPWpGaD
Loperamide—CALM3—DAP12 interactions—EGFR—cervical cancer	0.000143	0.00063	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR—EGFR—cervical cancer	0.000142	0.000624	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—HLA-DQB1—cervical cancer	0.000142	0.000622	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR in Cancer—EGFR—cervical cancer	0.000141	0.000618	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CA9—cervical cancer	0.000141	0.000617	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NOTCH2—cervical cancer	0.00014	0.000616	CbGpPWpGaD
Loperamide—CALM3—Signaling by PDGF—EGFR—cervical cancer	0.00014	0.000616	CbGpPWpGaD
Loperamide—CALM3—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	0.00014	0.000613	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—MTOR—cervical cancer	0.000139	0.000611	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR in disease—EGFR—cervical cancer	0.000139	0.000609	CbGpPWpGaD
Loperamide—CALM2—Fc epsilon receptor (FCERI) signaling—EGFR—cervical cancer	0.000139	0.000609	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR in disease—EGFR—cervical cancer	0.000139	0.000609	CbGpPWpGaD
Loperamide—CALM2—DAP12 interactions—EGFR—cervical cancer	0.000139	0.000609	CbGpPWpGaD
Loperamide—CALM1—DAP12 interactions—EGFR—cervical cancer	0.000139	0.000609	CbGpPWpGaD
Loperamide—CALM1—Fc epsilon receptor (FCERI) signaling—EGFR—cervical cancer	0.000139	0.000609	CbGpPWpGaD
Loperamide—CALM3—Signaling by WNT in cancer—CTNNB1—cervical cancer	0.000138	0.000605	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR—EGFR—cervical cancer	0.000138	0.000604	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR—EGFR—cervical cancer	0.000138	0.000604	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—HLA-DQB1—cervical cancer	0.000137	0.000602	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—HLA-DQB1—cervical cancer	0.000137	0.000602	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CA9—cervical cancer	0.000137	0.0006	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR in Cancer—EGFR—cervical cancer	0.000136	0.000598	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR in Cancer—EGFR—cervical cancer	0.000136	0.000598	CbGpPWpGaD
Loperamide—CALM1—Signaling by PDGF—EGFR—cervical cancer	0.000136	0.000596	CbGpPWpGaD
Loperamide—CALM2—Signaling by PDGF—EGFR—cervical cancer	0.000136	0.000596	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	0.000135	0.000593	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	0.000135	0.000593	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—MTOR—cervical cancer	0.000135	0.000591	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—MTOR—cervical cancer	0.000135	0.000591	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000134	0.000588	CbGpPWpGaD
Loperamide—CALM1—Signaling by WNT in cancer—CTNNB1—cervical cancer	0.000133	0.000585	CbGpPWpGaD
Loperamide—CALM2—Signaling by WNT in cancer—CTNNB1—cervical cancer	0.000133	0.000585	CbGpPWpGaD
Loperamide—CALM3—B Cell Activation—EGFR—cervical cancer	0.000133	0.000583	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD8A—cervical cancer	0.000132	0.000581	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CA9—cervical cancer	0.000132	0.000581	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CA9—cervical cancer	0.000132	0.000581	CbGpPWpGaD
Loperamide—CALM3—Disease—WNT5A—cervical cancer	0.000131	0.000575	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000129	0.000567	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—EGFR—cervical cancer	0.000128	0.000564	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—EGFR—cervical cancer	0.000128	0.000564	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD8A—cervical cancer	0.000128	0.000562	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD8A—cervical cancer	0.000128	0.000562	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—CASP3—cervical cancer	0.000128	0.000562	CbGpPWpGaD
Loperamide—CALM3—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000127	0.000558	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—STAT3—cervical cancer	0.000127	0.000557	CbGpPWpGaD
Loperamide—CALM1—Disease—WNT5A—cervical cancer	0.000127	0.000556	CbGpPWpGaD
Loperamide—CALM2—Disease—WNT5A—cervical cancer	0.000127	0.000556	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—CASP3—cervical cancer	0.000124	0.000543	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—CASP3—cervical cancer	0.000124	0.000543	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NOTCH2—cervical cancer	0.000123	0.00054	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000123	0.000539	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000123	0.000539	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—WNT2—cervical cancer	0.000121	0.000532	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CA9—cervical cancer	0.000119	0.000522	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—WNT2—cervical cancer	0.000117	0.000514	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—WNT2—cervical cancer	0.000117	0.000514	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—EGFR—cervical cancer	0.000115	0.000506	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HES1—cervical cancer	0.000115	0.000505	CbGpPWpGaD
Loperamide—CALM3—Signaling by Wnt—CTNNB1—cervical cancer	0.000114	0.000499	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—FGFR3—cervical cancer	0.000113	0.000495	CbGpPWpGaD
Loperamide—CALM3—Immune System—HLA-DPB1—cervical cancer	0.00011	0.000484	CbGpPWpGaD
Loperamide—CALM2—Signaling by Wnt—CTNNB1—cervical cancer	0.00011	0.000482	CbGpPWpGaD
Loperamide—CALM1—Signaling by Wnt—CTNNB1—cervical cancer	0.00011	0.000482	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—FGFR3—cervical cancer	0.000109	0.000479	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—FGFR3—cervical cancer	0.000109	0.000479	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—FGFR3—cervical cancer	0.000108	0.000475	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—STAT3—cervical cancer	0.000108	0.000472	CbGpPWpGaD
Loperamide—CALM2—Immune System—HLA-DPB1—cervical cancer	0.000107	0.000468	CbGpPWpGaD
Loperamide—CALM1—Immune System—HLA-DPB1—cervical cancer	0.000107	0.000468	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AKAP13—cervical cancer	0.000106	0.000467	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—FGFR3—cervical cancer	0.000105	0.00046	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—FGFR3—cervical cancer	0.000105	0.00046	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NOTCH2—cervical cancer	0.000104	0.000457	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—STAT3—cervical cancer	0.000104	0.000456	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—STAT3—cervical cancer	0.000104	0.000456	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CA9—cervical cancer	0.000104	0.000455	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AKAP13—cervical cancer	0.000103	0.000451	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AKAP13—cervical cancer	0.000103	0.000451	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000102	0.000449	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HES1—cervical cancer	0.000101	0.000443	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TERT—cervical cancer	0.000101	0.000443	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—EGFR—cervical cancer	9.77e-05	0.000429	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CA9—cervical cancer	9.77e-05	0.000429	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—TP53—cervical cancer	9.68e-05	0.000425	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CASP8—cervical cancer	9.64e-05	0.000423	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—EGFR—cervical cancer	9.45e-05	0.000415	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—EGFR—cervical cancer	9.45e-05	0.000415	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CASP8—cervical cancer	9.33e-05	0.000409	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CASP8—cervical cancer	9.33e-05	0.000409	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—FGFR3—cervical cancer	9.26e-05	0.000406	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—WNT5A—cervical cancer	9.18e-05	0.000403	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—WNT5A—cervical cancer	8.88e-05	0.00039	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—WNT5A—cervical cancer	8.88e-05	0.00039	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TERT—cervical cancer	8.85e-05	0.000388	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NOTCH1—cervical cancer	8.69e-05	0.000381	CbGpPWpGaD
Loperamide—CALM3—Immune System—HLA-DQB1—cervical cancer	8.6e-05	0.000377	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	8.59e-05	0.000377	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HES1—cervical cancer	8.53e-05	0.000374	CbGpPWpGaD
Loperamide—CALM2—Immune System—HLA-DQB1—cervical cancer	8.32e-05	0.000365	CbGpPWpGaD
Loperamide—CALM1—Immune System—HLA-DQB1—cervical cancer	8.32e-05	0.000365	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—FGFR3—cervical cancer	8.12e-05	0.000356	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD8A—cervical cancer	8.03e-05	0.000352	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—MTOR—cervical cancer	7.93e-05	0.000348	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CD4—cervical cancer	7.92e-05	0.000348	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD8A—cervical cancer	7.77e-05	0.000341	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD8A—cervical cancer	7.77e-05	0.000341	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—EGFR—cervical cancer	7.74e-05	0.00034	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—MTOR—cervical cancer	7.68e-05	0.000337	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—MTOR—cervical cancer	7.68e-05	0.000337	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CD4—cervical cancer	7.66e-05	0.000336	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CD4—cervical cancer	7.66e-05	0.000336	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NOTCH1—cervical cancer	7.62e-05	0.000335	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—MTOR—cervical cancer	7.62e-05	0.000334	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD4—cervical cancer	7.61e-05	0.000334	CbGpPWpGaD
Loperamide—CALM3—Disease—HES1—cervical cancer	7.54e-05	0.000331	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TERT—cervical cancer	7.48e-05	0.000328	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—MTOR—cervical cancer	7.37e-05	0.000323	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—MTOR—cervical cancer	7.37e-05	0.000323	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD4—cervical cancer	7.36e-05	0.000323	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD4—cervical cancer	7.36e-05	0.000323	CbGpPWpGaD
Loperamide—CALM2—Disease—HES1—cervical cancer	7.3e-05	0.00032	CbGpPWpGaD
Loperamide—CALM1—Disease—HES1—cervical cancer	7.3e-05	0.00032	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CTNNB1—cervical cancer	7.03e-05	0.000309	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—FGFR3—cervical cancer	6.86e-05	0.000301	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CTNNB1—cervical cancer	6.8e-05	0.000299	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CTNNB1—cervical cancer	6.8e-05	0.000299	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—EGFR—cervical cancer	6.79e-05	0.000298	CbGpPWpGaD
Loperamide—CALM3—Disease—MTHFR—cervical cancer	6.63e-05	0.000291	CbGpPWpGaD
Loperamide—CALM3—Disease—TERT—cervical cancer	6.61e-05	0.00029	CbGpPWpGaD
Loperamide—CALM3—Immune System—FGFR3—cervical cancer	6.57e-05	0.000288	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MTOR—cervical cancer	6.51e-05	0.000286	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOTCH2—cervical cancer	6.44e-05	0.000283	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NOTCH1—cervical cancer	6.44e-05	0.000283	CbGpPWpGaD
Loperamide—CALM1—Disease—MTHFR—cervical cancer	6.41e-05	0.000281	CbGpPWpGaD
Loperamide—CALM2—Disease—MTHFR—cervical cancer	6.41e-05	0.000281	CbGpPWpGaD
Loperamide—CALM1—Disease—TERT—cervical cancer	6.39e-05	0.000281	CbGpPWpGaD
Loperamide—CALM2—Disease—TERT—cervical cancer	6.39e-05	0.000281	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CA9—cervical cancer	6.39e-05	0.00028	CbGpPWpGaD
Loperamide—CALM1—Immune System—FGFR3—cervical cancer	6.35e-05	0.000279	CbGpPWpGaD
Loperamide—CALM2—Immune System—FGFR3—cervical cancer	6.35e-05	0.000279	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOTCH2—cervical cancer	6.23e-05	0.000273	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOTCH2—cervical cancer	6.23e-05	0.000273	CbGpPWpGaD
Loperamide—CALM3—Disease—FGFR3—cervical cancer	6.07e-05	0.000266	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CASP3—cervical cancer	5.99e-05	0.000263	CbGpPWpGaD
Loperamide—CALM2—Disease—FGFR3—cervical cancer	5.87e-05	0.000257	CbGpPWpGaD
Loperamide—CALM1—Disease—FGFR3—cervical cancer	5.87e-05	0.000257	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CTNNB1—cervical cancer	5.77e-05	0.000253	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—EGFR—cervical cancer	5.74e-05	0.000252	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MTOR—cervical cancer	5.71e-05	0.000251	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—MTHFR—cervical cancer	5.7e-05	0.00025	CbGpPWpGaD
Loperamide—CALM3—Disease—NOTCH1—cervical cancer	5.69e-05	0.00025	CbGpPWpGaD
Loperamide—CALM3—Immune System—CASP8—cervical cancer	5.62e-05	0.000247	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—EGFR—cervical cancer	5.57e-05	0.000245	CbGpPWpGaD
Loperamide—CALM3—Metabolism—MTHFR—cervical cancer	5.55e-05	0.000244	CbGpPWpGaD
Loperamide—CALM2—Disease—NOTCH1—cervical cancer	5.51e-05	0.000242	CbGpPWpGaD
Loperamide—CALM1—Disease—NOTCH1—cervical cancer	5.51e-05	0.000242	CbGpPWpGaD
Loperamide—CALM2—Immune System—CASP8—cervical cancer	5.43e-05	0.000238	CbGpPWpGaD
Loperamide—CALM1—Immune System—CASP8—cervical cancer	5.43e-05	0.000238	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—EGFR—cervical cancer	5.39e-05	0.000237	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—EGFR—cervical cancer	5.39e-05	0.000237	CbGpPWpGaD
Loperamide—CALM1—Metabolism—MTHFR—cervical cancer	5.37e-05	0.000236	CbGpPWpGaD
Loperamide—CALM2—Metabolism—MTHFR—cervical cancer	5.37e-05	0.000236	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—EGFR—cervical cancer	5.35e-05	0.000235	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HES1—cervical cancer	5.28e-05	0.000232	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CASP3—cervical cancer	5.25e-05	0.000231	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TP53—cervical cancer	5.2e-05	0.000228	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—EGFR—cervical cancer	5.18e-05	0.000227	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—EGFR—cervical cancer	5.18e-05	0.000227	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HES1—cervical cancer	5.11e-05	0.000224	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HES1—cervical cancer	5.11e-05	0.000224	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CTNNB1—cervical cancer	5.06e-05	0.000222	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—STAT3—cervical cancer	5.03e-05	0.000221	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TP53—cervical cancer	5.03e-05	0.000221	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TP53—cervical cancer	5.03e-05	0.000221	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—MTHFR—cervical cancer	4.83e-05	0.000212	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MTOR—cervical cancer	4.83e-05	0.000212	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TERT—cervical cancer	4.63e-05	0.000203	CbGpPWpGaD
Loperamide—CALM3—Immune System—MTOR—cervical cancer	4.62e-05	0.000203	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD4—cervical cancer	4.61e-05	0.000202	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—EGFR—cervical cancer	4.57e-05	0.000201	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TERT—cervical cancer	4.48e-05	0.000196	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TERT—cervical cancer	4.48e-05	0.000196	CbGpPWpGaD
Loperamide—CALM2—Immune System—MTOR—cervical cancer	4.47e-05	0.000196	CbGpPWpGaD
Loperamide—CALM1—Immune System—MTOR—cervical cancer	4.47e-05	0.000196	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD4—cervical cancer	4.46e-05	0.000196	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD4—cervical cancer	4.46e-05	0.000196	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CASP3—cervical cancer	4.44e-05	0.000195	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—STAT3—cervical cancer	4.41e-05	0.000194	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CTNNB1—cervical cancer	4.28e-05	0.000188	CbGpPWpGaD
Loperamide—CALM3—Disease—MTOR—cervical cancer	4.27e-05	0.000187	CbGpPWpGaD
Loperamide—CALM3—Disease—CD4—cervical cancer	4.26e-05	0.000187	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—FGFR3—cervical cancer	4.25e-05	0.000186	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—MTHFR—cervical cancer	4.21e-05	0.000185	CbGpPWpGaD
Loperamide—CALM1—Disease—MTOR—cervical cancer	4.13e-05	0.000181	CbGpPWpGaD
Loperamide—CALM2—Disease—MTOR—cervical cancer	4.13e-05	0.000181	CbGpPWpGaD
Loperamide—CALM2—Disease—CD4—cervical cancer	4.12e-05	0.000181	CbGpPWpGaD
Loperamide—CALM1—Disease—CD4—cervical cancer	4.12e-05	0.000181	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—FGFR3—cervical cancer	4.11e-05	0.00018	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—FGFR3—cervical cancer	4.11e-05	0.00018	CbGpPWpGaD
Loperamide—CALM3—Immune System—CTNNB1—cervical cancer	4.1e-05	0.00018	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—EGFR—cervical cancer	4.01e-05	0.000176	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOTCH1—cervical cancer	3.99e-05	0.000175	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MTHFR—cervical cancer	3.96e-05	0.000174	CbGpPWpGaD
Loperamide—CALM2—Immune System—CTNNB1—cervical cancer	3.96e-05	0.000174	CbGpPWpGaD
Loperamide—CALM1—Immune System—CTNNB1—cervical cancer	3.96e-05	0.000174	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOTCH1—cervical cancer	3.86e-05	0.000169	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOTCH1—cervical cancer	3.86e-05	0.000169	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—cervical cancer	3.84e-05	0.000169	CbGpPWpGaD
Loperamide—CALM3—Disease—CTNNB1—cervical cancer	3.78e-05	0.000166	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—STAT3—cervical cancer	3.73e-05	0.000164	CbGpPWpGaD
Loperamide—CALM2—Disease—CTNNB1—cervical cancer	3.66e-05	0.000161	CbGpPWpGaD
Loperamide—CALM1—Disease—CTNNB1—cervical cancer	3.66e-05	0.000161	CbGpPWpGaD
Loperamide—CALM3—Immune System—STAT3—cervical cancer	3.57e-05	0.000157	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—EGFR—cervical cancer	3.55e-05	0.000156	CbGpPWpGaD
Loperamide—CALM1—Immune System—STAT3—cervical cancer	3.45e-05	0.000152	CbGpPWpGaD
Loperamide—CALM2—Immune System—STAT3—cervical cancer	3.45e-05	0.000152	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—EGFR—cervical cancer	3.44e-05	0.000151	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—EGFR—cervical cancer	3.44e-05	0.000151	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EGFR—cervical cancer	3.39e-05	0.000149	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—cervical cancer	3.37e-05	0.000148	CbGpPWpGaD
Loperamide—CALM3—Disease—STAT3—cervical cancer	3.3e-05	0.000145	CbGpPWpGaD
Loperamide—CALM3—Immune System—EGFR—cervical cancer	3.25e-05	0.000142	CbGpPWpGaD
Loperamide—CALM1—Disease—STAT3—cervical cancer	3.19e-05	0.00014	CbGpPWpGaD
Loperamide—CALM2—Disease—STAT3—cervical cancer	3.19e-05	0.00014	CbGpPWpGaD
Loperamide—CALM2—Immune System—EGFR—cervical cancer	3.14e-05	0.000138	CbGpPWpGaD
Loperamide—CALM1—Immune System—EGFR—cervical cancer	3.14e-05	0.000138	CbGpPWpGaD
Loperamide—CALM3—Disease—EGFR—cervical cancer	3e-05	0.000132	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MTOR—cervical cancer	2.99e-05	0.000131	CbGpPWpGaD
Loperamide—CALM2—Disease—EGFR—cervical cancer	2.9e-05	0.000127	CbGpPWpGaD
Loperamide—CALM1—Disease—EGFR—cervical cancer	2.9e-05	0.000127	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MTOR—cervical cancer	2.89e-05	0.000127	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MTOR—cervical cancer	2.89e-05	0.000127	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—cervical cancer	2.85e-05	0.000125	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CASP3—cervical cancer	2.75e-05	0.000121	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CASP3—cervical cancer	2.66e-05	0.000117	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CASP3—cervical cancer	2.66e-05	0.000117	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CTNNB1—cervical cancer	2.65e-05	0.000116	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MTHFR—cervical cancer	2.59e-05	0.000114	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CTNNB1—cervical cancer	2.56e-05	0.000112	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CTNNB1—cervical cancer	2.56e-05	0.000112	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—STAT3—cervical cancer	2.31e-05	0.000101	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—STAT3—cervical cancer	2.23e-05	9.8e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—STAT3—cervical cancer	2.23e-05	9.8e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EGFR—cervical cancer	2.1e-05	9.21e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EGFR—cervical cancer	2.03e-05	8.91e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EGFR—cervical cancer	2.03e-05	8.91e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—cervical cancer	1.76e-05	7.73e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—cervical cancer	1.7e-05	7.48e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—cervical cancer	1.7e-05	7.48e-05	CbGpPWpGaD
